Octarine Bio ApS
Private limited companyCVR 39857316København ØActive
Octarine Bio ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2018. The company made a loss in both 2024 and 2025, most recently DKK 11.5m. With 21 employees, the company is about 4 times larger than the industry median. 6 people are registered in the company's management and ownership.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 342% (2024 → 2025), to DKK 1.7m.
- The loss got smaller: from DKK 22.3m to DKK 11.5m (2024 → 2025).
- Equity turned positive again: DKK 31.9m (2024 → 2025).
Employees
- 8 more employees than a year earlier: 21 (07/2026) against 13 (07/2025).
Management and owners, last 24 months
- New in management: Marianne Tochtermann (board member, 17/12/2025), Anna Søndergaard (board member, 18/09/2026) and Jonas Ahm-Lundgren (board member, 14/07/2025) (+1).
- Stepped down: Helga Claudia Blomgren-Hansen (board member, 17/12/2025), Jonas Ahm-Lundgren (board member, 18/09/2026) and Anna Sophie Zimmermann (board member, 01/01/2026).
- New owners registered: Nicholas Stuart William Milne (14/07/2025), Biosphere ApS (14/07/2025) and UV Fund I K/S (14/07/2025) (+6).
- No longer registered as owner: Nicholas Stuart William Milne (13/07/2025), Biosphere ApS (13/07/2025) and Danmarks Eksport- og Investeringsfond (13/07/2025) (+3).
Registrations, last 24 months
- 17/12/2025: Share capital changed from 103,492 DKK to 110,436 DKK
- 14/07/2025: Share capital changed from 57,167 DKK to 103,492 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 917 | 1,682 | 1,378 | 1,089 | 388 | 1,715 | +342.3% |
| Profit before tax | – | – | – | – | −26,552 | −14,235 | +46.4% |
| Net profit | −2,373 | −6,419 | −9,671 | −19,292 | −22,299 | −11,501 | +48.4% |
| Total assets | 9,332 | 14,676 | 15,340 | 34,789 | 27,908 | 36,684 | +31.4% |
| Equity | −900 | 6,527 | −3,145 | −22,437 | −44,736 | 31,908 | +171.3% |
| Liabilities | 10,232 | 8,149 | 18,485 | 57,226 | 72,644 | 4,776 | −93.4% |
| Cash and cash equivalents | 6,206 | 10,950 | 9,286 | 20,056 | 12,009 | 15,974 | +33% |
| Average number of employees | 3 | 7 | 9 | 9 | 11 | 11 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 24/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 19/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 17/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 20/06/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 21/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 12/05/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 20–49 employees9,922 companies in the comparison | No. 9,257of 9,892 Better than 6% | No. 1,127of 9,922 Better than 89% |
| Same industry and 20–49 employees64 companies in the comparison | No. 39of 62 Better than 38% | No. 29of 64 Better than 56% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 18,354of 33,588 Better than 45% | No. 1,678of 33,687 Better than 95% |
| All companies of type ApS66,508 companies in the comparison | No. 32,982of 66,379 Better than 50% | No. 3,015of 66,505 Better than 95% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Octarine Bio ApSDKK 1.7m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Octarine Bio ApS−DKK 11.5m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Octarine Bio ApSDKK 31.9m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Octarine Bio ApS21
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Nicholas Stuart William Milne10%
- Biosphere ApS15%
- UV Fund I K/S5%
- Danmarks Eksport- og Investeringsfond5%
- The Footprint Fund I K/S10%
- Oskare Fund I5%
- DSM Venturing B.V.5%
- Ginkgo Bioworks, Inc.5%
Management
8 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Nethaji Janeshawari Gallage | CEO | 12/09/2018 |
| Nicholas Stuart William Milne | Director | 12/09/2018 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Stephan Christgau | Chair of the board | 30/06/2020 |
| Alexandre Ouimet-Storrs | Board member | 10/09/2020 |
| Akshat Kshetrapal | Board member | 15/12/2021 |
| Nethaji Janeshawari Gallage | Board member | 01/08/2022 |
| Marianne Tochtermann | Board member | 17/12/2025 |
| Anna Søndergaard | Board member | 18/09/2026 |
- Founders
- Nicholas Stuart William Milne, Biosphere ApS
Former management (5)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Helga Claudia Blomgren-Hansen | Board member | 30/06/2020 | 17/12/2025 |
| Christian Brix Tillegreen | Board member | 30/06/2020 | 31/12/2022 |
| Lene Gerlach | Board member | 05/03/2021 | 31/12/2022 |
| Jonas Ahm-Lundgren | Board member | 14/07/2025 | 18/09/2026 |
| Anna Sophie Zimmermann | Board member | 01/01/2026 | 01/01/2026 |
Signing rule: Selskabet tegnes af et bestyrelsesmedlem og en direktør i forening eller af den samlede bestyrelse
Address and production units
1 active production unitsLersø Parkallé 42
2100 København Ø
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Octarine Bio ApS | Lersø Parkallé 42, 1, 2100 København Ø | 20 | 1023949306 |
Purpose
1.2 Selskabets formål er at drive forsknings- og udviklingsvirksomhed indenfor sundhed og kosmetisk pleje og hermed beslægtet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
65 registered events20265 changesmanagement 4 · accounts 1
- ManagementAnna Søndergaard appointed board member
- ManagementJonas Ahm-Lundgren stepped down as board member
- AccountsAnnual report for 2025 published
- ManagementAnna Sophie Zimmermann appointed board member
- ManagementAnna Sophie Zimmermann stepped down as board member
202522 changescapital 2 · management 3 · ownership 15 · accounts 1 · industry 1
- CapitalShare capital changed from 103,492 DKK to 110,436 DKK
- ManagementMarianne Tochtermann appointed board member
- ManagementHelga Claudia Blomgren-Hansen stepped down as board member
- OwnershipGinkgo Bioworks, Inc. registered as owner (5%)
- OwnershipGinkgo Bioworks, Inc. is no longer registered as owner
- CapitalShare capital changed from 57,167 DKK to 103,492 DKK
- ManagementJonas Ahm-Lundgren appointed board member
- OwnershipGinkgo Bioworks, Inc. registered as owner (10%)
- OwnershipDSM Venturing B.V. registered as owner (5%)
- OwnershipOskare Fund I registered as owner (5%)
- OwnershipThe Footprint Fund I K/S registered as owner (10%)
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (5%)
- OwnershipUV Fund I K/S registered as owner (5%)
- OwnershipBiosphere ApS registered as owner (15%)
- OwnershipNicholas Stuart William Milne registered as owner (10%)
- OwnershipOskare Fund I is no longer registered as owner
- OwnershipThe Footprint Fund I K/S is no longer registered as owner
- OwnershipDanmarks Eksport- og Investeringsfond is no longer registered as owner
- OwnershipBiosphere ApS is no longer registered as owner
- OwnershipNicholas Stuart William Milne is no longer registered as owner
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20244 changesaccounts 1 · ownership 3
- AccountsAnnual report for 2023 published
- OwnershipOskare Fund I registered as owner (5%)
- OwnershipThe Footprint Fund I K/S registered as owner (5%)
- OwnershipRiver Stone Biotech ApS is no longer registered as owner
20232 changesaccounts 1 · ownership 1
- AccountsAnnual report for 2022 published
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (10%)
20225 changesmanagement 3 · address 1 · accounts 1
- ManagementLene Gerlach stepped down as board member
- ManagementChristian Brix Tillegreen stepped down as board member
- AddressMoved to Lersø Parkallé 42, 1, 2100 København Ø
- ManagementNethaji Janeshawari Gallage appointed board member
- AccountsAnnual report for 2021 published
202110 changesmanagement 2 · accounts 1 · capital 1 · ownership 6
- ManagementAkshat Kshetrapal appointed board member
- AccountsAnnual report for 2020 published
- CapitalShare capital changed from 40,000 DKK to 57,167 DKK
- ManagementLene Gerlach appointed board member
- OwnershipBiosphere ApS registered as owner (33.33%)
- OwnershipRiver Stone Biotech ApS registered as owner (10%)
- OwnershipNicholas Stuart William Milne registered as owner (20%)
- OwnershipRiver Stone Biotech ApS is no longer registered as owner
- OwnershipBiosphere ApS is no longer registered as owner
- OwnershipNicholas Stuart William Milne is no longer registered as owner
202011 changesname 1 · capital 1 · ownership 5 · management 4
- NameName changed from Octarine Bio IVS to Octarine Bio ApS
- CapitalShare capital changed from 1,000 DKK to 40,000 DKK
- OwnershipRiver Stone Biotech ApS registered as owner (20%)
- OwnershipBiosphere ApS registered as owner (33.33%)
- OwnershipNicholas Stuart William Milne registered as owner (25%)
- OwnershipBiosphere ApS is no longer registered as owner
- OwnershipNicholas Stuart William Milne is no longer registered as owner
- ManagementAlexandre Ouimet-Storrs appointed board member
- ManagementHelga Claudia Blomgren-Hansen appointed board member
- ManagementChristian Brix Tillegreen appointed board member
- ManagementStephan Christgau appointed chair of the board
20191 changeaddress 1
- AddressMoved to Fruebjergvej 3, 2100 København Ø
20185 changesfounded 1 · management 2 · ownership 2
- FoundedRegistered as Octarine Bio IVS
- ManagementNicholas Stuart William Milne appointed director
- ManagementNethaji Janeshawari Gallage appointed ceo
- OwnershipBiosphere ApS registered as owner (50%)
- OwnershipNicholas Stuart William Milne registered as owner (33.33%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- DK Company A/Svia Marianne Tochtermann
- DK Company Vejle A/Svia Marianne Tochtermann
- DK Company Cph A/Svia Marianne Tochtermann
- NMD Pharma A/Svia Stephan Christgau
- Wheat A/Svia Marianne Tochtermann
- The Footprint Firm ApSvia Anna Søndergaard
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.